Various imaging modalities are used throughout the process of drug discovery and development, both in the preclinical and clinical phases.

According to analysts, Valuates, the global preclinical imaging market was valued at $1887.9 million in 2023 and is anticipated to reach $3021.2 million by 2030.

As the demand for personalised medicine and targeted therapies grows, the need for customised imaging solutions in drug discovery becomes more pronounced, and the rise in the use of automation and artificial intelligence is having a significant impact.

This eBook, sponsored by Aurora Microplates, examines the role of imaging and its significance to the success of drug discovery and development.

Download this exclusive eBook to learn more about:

  • Two technological developments that have revolutionised the role of imaging in drug discovery
  • The latest innovations in flow cytometry technology
  • The role of AI-powered imaging analytics in clinical trials
  • Real cases of how imaging techniques are advancing drug discovery

Download for free now.